Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,592.40
(
0.20%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.81
(
-2.25%
)
Bitcoin
70,303.02
(
-1.49%
)
News Focus
News Focus
Post# of 257683
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123050
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 135560

Tuesday, 01/24/2012 6:03:35 PM

Tuesday, January 24, 2012 6:03:35 PM

Post# of 257683

BAX…if another [disease-modifying] drug launched, gammagard could not compete on price. it would need to be much more effective to get payors to cover.

What’s the likelihood that two disease-modifying agents for AD will be approved in the next few years? It must be pretty darn small.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today